Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
Nat Chem Biol. 2010 Dec;6(12):907-13. doi: 10.1038/nchembio.466. Epub 2010 Oct 31.
Deficiency of glucocerebrosidase (GBA) underlies Gaucher disease, a common lysosomal storage disorder. Carriership for Gaucher disease has recently been identified as major risk for parkinsonism. Presently, no method exists to visualize active GBA molecules in situ. We here report the design, synthesis and application of two fluorescent activity-based probes allowing highly specific labeling of active GBA molecules in vitro and in cultured cells and mice in vivo. Detection of in vitro labeled recombinant GBA on slab gels after electrophoresis is in the low attomolar range. Using cell or tissue lysates, we obtained exclusive labeling of GBA molecules. We present evidence from fluorescence-activated cell sorting analysis, fluorescence microscopy and pulse-chase experiments of highly efficient labeling of GBA molecules in intact cells as well as tissues of mice. In addition, we illustrate the use of the fluorescent probes to study inhibitors and tentative chaperones in living cells.
葡糖脑苷脂酶(GBA)的缺乏是戈谢病的基础,这是一种常见的溶酶体贮积症。戈谢病的携带者最近被确定为帕金森病的主要危险因素。目前,尚无方法可以在体内原位可视化活性 GBA 分子。我们在此报告了两种荧光活性基探针的设计、合成和应用,这些探针允许在体外和培养的细胞和体内的小鼠中高度特异性地标记活性 GBA 分子。电泳后在平板凝胶上检测到体外标记的重组 GBA 的浓度低至皮摩尔级。使用细胞或组织裂解物,我们获得了 GBA 分子的特异性标记。我们通过荧光激活细胞分选分析、荧光显微镜和脉冲追踪实验提供了证据,证明了在完整细胞以及小鼠组织中 GBA 分子的高效标记。此外,我们还说明了荧光探针在活细胞中研究抑制剂和试探性伴侣分子的用途。